{"name":"Pfenex, Inc","slug":"pfenex-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":14857000,"revenueGrowth":343.4,"grossMargin":0,"rdSpend":25533000,"netIncome":1058000,"cash":84887000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2018"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Teriparatide (PF708)","genericName":"Teriparatide (PF708)","slug":"teriparatide-pf708","indication":"Treatment of osteoporosis in postmenopausal women and men with a high risk of fractures","status":"phase_3"}]}],"pipeline":[{"name":"Teriparatide (PF708)","genericName":"Teriparatide (PF708)","slug":"teriparatide-pf708","phase":"phase_3","mechanism":"Teriparatide is a recombinant form of parathyroid hormone used to treat osteoporosis by stimulating bone growth.","indications":["Treatment of osteoporosis in postmenopausal women and men with a high risk of fractures"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE0yeFNhbUd6YXJySWxHNDZqNHl4S3lwT2Q5Q0o1V0dVSDlVaDZMN2dSM3MxQWthbzA0VGZWVUJPNGUxN3FlbTZBaEtrQkJvMk1WYlRPbWxReHdYSmlwbnc?oc=5","date":"2026-03-16","type":"earnings","source":"Stock Titan","summary":"Latest LGND News - Ligand’s Third Quarter Financial Results to... - Stock Titan","headline":"Latest LGND News - Ligand’s Third Quarter Financial Results to...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNNmpKTzdqVXZDb0ZKcTNsM1QzTmpWcWJBd2p2R1RKeTJaUmhrVWMyY0xWWDFKdWNfbzlFVXJ3V3FscTVOOV9FeGh6VTRMWkxHTUFySUhqdXpLN2h0aTVqZnJPRVM3ZVpDVHdhRHdKQm5kTGIyNEt4VG9PcXBHMTNjOQ?oc=5","date":"2023-03-29","type":"pipeline","source":"San Diego Business Journal","summary":"LENZ Therapeutics Closes $83.5M Series B - San Diego Business Journal","headline":"LENZ Therapeutics Closes $83.5M Series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQTEZJNHVLY2swZmQ5ZzI2djYxaHRRc0g1TzlWVWEtMWh1Z1ZqNjN1dE0zUlpwb0dpbTh0UmR1YVpFbVV3STBPUzVEXzV5dmhMRGxsckFMRTBZcmxkZ2hQUW1ubEwyend2dUhDSDhSc3ZDX1ZTNGh3YVFHZTdELTNZNWFjeTZETHZIdUVRbG9NeTFSVEtqVVpPc05B?oc=5","date":"2021-09-13","type":"pipeline","source":"Fierce Biotech","summary":"Where are they now? Tracking down 2011’s Fierce 15 - Fierce Biotech","headline":"Where are they now? Tracking down 2011’s Fierce 15","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNQU9VMDlRNmswYWt4cTFPb1hOaUhsTnF2VXNYTUp0Ym9SWjdOakV6TWNHQk0wR1RSN3RmNDlOMjZBSEoyZjhnQ2M0ZVcxa01KdG16OWtuUmQxUHN0S2x4Um8zR0s3bnBzMVZXT2R5aDBfTkptQUF5b21GbzZpX3hEbU1VUm9mdjdyMVhfWWpKUmhrQzFDeDVTZTVVWlYyTzNHZHpnV1RhNHQ5dmFhN2FLVnZ4d3NsLVk5QVE?oc=5","date":"2021-06-17","type":"pipeline","source":"LENZ Therapeutics","summary":"LENZ Therapeutics Debuts With $47 Million Series A Financing - LENZ Therapeutics","headline":"LENZ Therapeutics Debuts With $47 Million Series A Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5jbTlTWHBWX0JzaEl3OTBTMTlaQ1RDRXNWQk1TRS1pMmR1NlQxNFF1RWpLdUlYclNNeFJSeU8yLUZ6d0hpbjFJRXZSS1dZV0JNdlF5bThxSzFnZFdFbXJXZExaOFBxWld2alY1QW1mbHhYbmp4eHc4V0hB?oc=5","date":"2020-08-11","type":"deal","source":"Pharmaceutical Technology","summary":"Ligand Pharmaceuticals agrees to acquire Pfenex for $516m - Pharmaceutical Technology","headline":"Ligand Pharmaceuticals agrees to acquire Pfenex for $516m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5EaUhHZmVZOERLUDBmVjFJazZUMkRubGVfakNvb2dvUUVkYVJad2s1X2IxdmxBQXowRTBXYi13cGlXYTNUNDVla3VhdnQ2ZHZFQ3ZYVWVFTFNWQXE4LUxWVmxONEJIcUJLSVJn?oc=5","date":"2020-08-11","type":"deal","source":"BioSpace","summary":"Ligand Buys Pfenex in $516 Million Deal to Access Protein Production Platform - BioSpace","headline":"Ligand Buys Pfenex in $516 Million Deal to Access Protein Production Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQeUlpZDlGZkJKOTBlMUEwZkphS1JNQU5tNDY3TFBEc1p3Z1VLN3ZWZTV5QjAzdEh0Q2d3YjZjQ19wZVBRdFkySnVRWU1fRkR1Q2IweEhVcUVQcGFueVM4dnd1LTlrZ1RNVm1Wcmt6X1NHNU0tU1FmbVdwd1Y0TnpHdWFQTnJ6TnZHdTNiNVgzcw?oc=5","date":"2020-08-10","type":"deal","source":"Business Wire","summary":"Ligand to Acquire Pfenex Inc. - Business Wire","headline":"Ligand to Acquire Pfenex Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNanEwekFKYVhFVzdtNHNlWE04V2tpNVQ1bEU4S0pWU3ZmdDVkWjNsQmp1QjlheXVKTG5GOW5RV0MzbE53MFdHM2RYVFNqbVV6VGtacVZacnBNNkJlbmY0T3ZMcTYtQnhqbVJEOURSdmFFQlh4a2w1YWZ2OWVEcW9QZmlSSU9OejNHNmhUZUJTak9sTzloMElyd2xTS2R5VzVneTBEOWV1ajlTNUpIZ2czWUl6SXdhQlFTWVZJUE1lenVxWS1KTFZhQ3pGUHFON3VxblFRUk02NXpxcmpxYzR6LXJENHdHLW84YUVGazdUcWQ0dEZOOVFnZlZscGlNcXRL?oc=5","date":"2017-12-19","type":"deal","source":"PR Newswire","summary":"Pfenex earns $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals - PR Newswire","headline":"Pfenex earns $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1YYXM4a2Q2d2dpTzgxMktiWWRvM1VoMm5fc1pBTW03Nkl4dWlrQWEyRVhZMkNxRmttV1FOOEdGVnpZZmU4QkZOdWFFTkstTUpwSk9Ma3g2dnpmMjRCSTQ4Q0ZmY3VVNHc5MlhuamhrOWdnQjJyM01CZHd3?oc=5","date":"2017-01-24","type":"pipeline","source":"BioSpace","summary":"Pfenex Release: CEO Ousted, Interim Chief Named - BioSpace","headline":"Pfenex Release: CEO Ousted, Interim Chief Named","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":14857000,"revenuePeriod":"2018-12-31","revenueHistory":[{"value":14857000,"period":"2018-12-31"},{"value":3351000,"period":"2018-12-31"},{"value":3570000,"period":"2018-09-30"},{"value":4190000,"period":"2018-06-30"},{"value":3746000,"period":"2018-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":25533000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":1058000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":84887000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}